Increased density of GAD65/67 immunoreactive neurons in the posterior subiculum and parahippocampal gyrus in treated patients with chronic schizophrenia

World Journal of Biological Psychiatry

Volumn 12, Issue 1, 2011, Pages 57-65

  Schreiber, Stefanie ^a   Bernstein, Hans Gert ^a   Fendrich, Robert ^b   Stauch, Renate ^a   Ketzler, Bianca ^a   Dobrowolny, Henrik ^a   Steiner, Johann ^a   Schreiber, Frank ^c   Bogerts, Bernhard ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b DARTMOUTH COLLEGE   (United States)

^c TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

antipsychotics; Biological psychiatry; negative symptoms; neuropathology; schizophrenia

Indexed keywords

GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67;

ARTICLE; BRAIN CORTEX; BRAIN SIZE; CELL DENSITY; CONTROLLED STUDY; DISEASE DURATION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; NERVE CELL; NEUROPATHOLOGY; PARAHIPPOCAMPAL GYRUS; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA; SUBICULUM;

CHRONIC DISEASE; FEMALE; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NEURONS; PARAHIPPOCAMPAL GYRUS; SCHIZOPHRENIA;

EID: 79551583291     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2010.539270     Document Type: Article

References (48)

1. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE, Jones EG. 1995. Gene expression for glutamic acid decar-boxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52(4): 258-266.
2. Andersen BB, Korbo L, Pakkenberg B. 1992. A quantitative study of the human cerebellum with unbiased stereological techniques. J Comp Neurol 326(4):549-560.
3. Bernstein HG, Baumann B, Danos P, Diekmann S, Bogerts B, Gundelfinger ED, Braunewell KH. 1999. Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain. J Neurocytol 28(8): 655-662.
4. Bielau H, Mawrin C, Krell D, Agelink MW, Trubner K, Davis R, et al. 2005. Differences in activation of the dorsal raphe nucleus depending on performance of suicide. Brain Res 1039(1-2):43-52.
5. Blum BP, Mann JJ. 2002. The GABAergic system in schizophrenia. Int J Neuropsychopharmacol 5(2):159-179.
6. Braak H. 1974. On the structure of the human archicortex. I. The cornu ammonis. A Golgi and pigmentarchitectonic study. Cell Tissue Res 152(3):349-383.
7. Braak H. 1978. Pigment architecture of the human telencephalic cortex. III. Regio praesubicularis. Cell Tissue Res 190(3): 509-523.
8. Brooke SM, Haas-Johnson AM, Kaplan JR, Sapolsky RM. 1994. Characterization of mineralocorticoid and glucocorticoid receptors in primate brain. Brain Res 637(1-2):303-307.
9. Bu DF, Erlander MG, Hitz BC, Tillakaratne NJ, Kaufman DL, Wagner-McPherson CB, et al. 1992. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA 89(6): 2115-2119.
10. Cho RY, Konecky RO, Carter CS. 2006. Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci USA 103(52):19878-19883.
11. Danos P, Baumann B, Kramer A, Bernstein HG, Stauch R, Krell D, et al. 2003. Volumes of association thalamic nuclei in schizophrenia: a postmortem study. Schizophr Res 60(2-3): 141-155.
12. Dong HW, Swanson LW. 2006. Projections from bed nuclei of the stria terminalis, anteromedial area: cerebral hemisphere integration of neuroendocrine, autonomic, and behavioral aspects of energy balance. J Comp Neurol 494(1):142-178.
13. Dracheva S, Elhakem SL, McGurk SR, Davis KL, Haroutunian V. 2004. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J Neurosci Res 76(4):581-592.
14. Eyler LT, Jeste DV, Brown GG. 2008. Brain response abnormalities during verbal learning among patients with schizophrenia. Psychiatry Res 162(1):11-25.
15. Falkai P, Schneider-Axmann T, Honer WG. 2000. Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality. Biol Psychiatry 47(11):937-943.
16. Fanselow MS, Dong HW. 2010. Are the dorsal and ventral hippocampus functionally distinct structures? Neuron 65(1): 7-19.
17. Fatemi SH, Stary JM, Earle JA, Araghi-Niknam M, Eagan E. 2005. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decar-boxylase 65 and 67 kDa and Reelin proteins in cerebellum. Schizophr Res 72(2-3):109-122.
18. Gluck MR, Thomas RG, Davis KL, Haroutunian V. 2002. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. Am J Psychiatry 159(7):1165-1173.
19. Groenewegen HJ, Russchen FT. 1984. Organization of the efferent projections of the nucleus accumbens to pallidal, hypothalamic, and mesencephalic structures: a tracing and immunohistochemical study in the cat. J Comp Neurol 223(3): 347-367.
20. Guerra-Araiza C, Miranda-Martinez A, Neri-Gomez T, Camacho-Arroyo I. 2008. Sex steroids effects on the content of GAD, TH, GABA(A), and glutamate receptors in the olfactory bulb of the male rat. Neurochem Res 33(8): 1568-1573.
21. Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR, et al. 2000. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 57(11):1061-1069.
22. Haenschel C, Bittner RA, Waltz J, Haertling F, Wibral M, Singer W, et al. 2009. Cortical oscillatory activity is critical for working memory as revealed by deficits in early-onset schizophrenia. J Neurosci 29(30):9481-9489.
23. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, et al. 2001. Genome-wide expression analysis reveals dysregu-lation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98(8):4746-4751.
24. Heckers S, Stone DJ, Walsh J, Shick J, Koul P, Benes FM. 2002. Differential hippocampal expression of glutamic acid decar-boxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry 59(6):521-529.
25. Hikosaka O, Wurtz RH. 1983. Visual and oculomotor functions of monkey substantia nigra pars reticulata. I V. Relation of sub-stantia nigra to superior colliculus. J Neurophysiol 49(5): 1285-1301.
26. Issa G, Wilson C, Terry AV Jr, Pillai A. 2010. An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies. Neurobiol Dis. 39(3):327-333.
27. Kaufman DL, Houser CR, Tobin AJ. 1991. Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decar-boxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem 56(2):720-723.
28. McMillan PJ, Wilkinson CW, Greenup L, Raskind MA, Peskind ER, Leverenz JB. 2004. Chronic cortisol exposure promotes the development of a GABAergic phenotype in the primate hippocampus. J Neurochem 91(4):843-851.
29. Nesvaderani M, Matsumoto I, Sivagnanasundaram S. 2009. Anterior hippocampus in schizophrenia pathogenesis: molecular evidence from a proteome study. Aust N Z J Psychiatry 43(4):310-322.
30. Ongur D, Prescot AP, McCarthy J, Cohen BM, Renshaw PF. 2010. Elevated Gamma-Aminobutyric Acid Levels in Chronic Schizophrenia. Biol Psychiatry 68(7):667-70.
31. Pegues MP, Rogers LJ, Amend D, Vinogradov S, Deicken RF. 2003. Anterior hippocampal volume reduction in male patients with schizophrenia. Schizophr Res 60(2-3):105-115.
32. Roberts AC, Tomic DL, Parkinson CH, Roeling TA, Cutter DJ, Robbins TW, Everitt BJ. 2007. Forebrain connectivity of the prefrontal cortex in the marmoset monkey ( Callithrix jacchus ): an anterograde and retrograde tract-tracing study. J Comp Neurol 502(1):86-112.
33. Ryan MC, SharifiN, Condren R, Thakore JH. 2004. Evidence of basal pituitary-adrenal overactivity in first episode, drug naive patients with schizophrenia. Psychoneuroendocrinology 29(8):1065-1070.
34. Satta R, Maloku E, Zhubi A, Pibiri F, Hajos M, Costa E, Guidotti A. 2008. Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons. Proc Natl Acad Sci USA 105(42):16356-16361.
35. Schmitt A, Steyskal C, Bernstein HG, Schneider-Axmann T, Parlapani E, Schaeffer EL, et al. 2009. Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathol 117(4):395-407.
36. Steullet P, Cabungcal JH, Kulak A, Kraftsik R, Chen Y, Dalton TP, et al. 2010. Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors. J Neurosci 30(7): 2547-2558.
37. Stokes PE. 1995. The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. Eur Neuropsychopharmacol 5 (Suppl):77-82.
38. Stone DJ, Walsh JP, Sebro R, Stevens R, Pantazopolous H, Benes FM. 2001. Effects of pre- and postnatal corticosterone exposure on the rat hippocampal GABA system. Hippocampus 11(5):492-507.
39. Swanson CJ, Kalivas P W. 2000. Regulation of locomotor activity by metabotropic glutamate receptors in the nucleus accumbens and ventral tegmental area. J Pharmacol Exp Ther 292(1):406-414.
40. Thanvi B, Treadwell S. 2009. Drug induced parkinsonism: a common cause of parkinsonism in older people. Postgrad Med J 85(1004):322-326.
41. Thompson M, Weickert CS, Wyatt E, Webster MJ. 2009. Decreased glutamic acid decarboxylase (67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. J Psychiatr Res. 43(11):970-7.
42. Todtenkopf MS, Benes FM. 1998. Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain. Synapse 29(4):323-332.
43. Uhlhaas PJ, Singer W. 2010. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11(2):100-113.
44. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis D. 2000. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 57(3):237-245.
45. Walker MA, Highley JR, Esiri MM, McDonald B, Roberts HC, Evans SP, Crow TJ. 2002. Estimated neuronal populations and volumes of the hippocampus and its subfields in schizophrenia. Am J Psychiatry 159:821-828.
46. West MJ, Slomianka L. 1998. Total number of neurons in the layers of the human entorhinal cortex. Hippocampus 8(1):69-82.
47. Zech M, Roberts GW, Bogerts B, Crow TJ, Polak JM. 1986. Neu-ropeptides in the amygdala of controls, schizophrenics and patients suffering from Huntington's chorea: an immunohistochemical study. Acta Neuropathol 71(3-4):259-266.
48. Zink M, Schmitt A, May B, Muller B, Demirakca T, Braus DF, Henn FA. 2004. Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression.De. Schizophr Res 66(2-3):151-157.